280 related articles for article (PubMed ID: 23958066)
1. RGTA-based matrix therapy in severe experimental corneal lesions: safety and efficacy studies.
Brignole-Baudouin F; Warnet JM; Barritault D; Baudouin C
J Fr Ophtalmol; 2013 Nov; 36(9):740-7. PubMed ID: 23958066
[TBL] [Abstract][Full Text] [Related]
2. [Pilot study of a new matrix therapy agent (RGTA OTR4120) in treatment-resistant corneal ulcers and corneal dystrophy].
Chebbi CK; Kichenin K; Amar N; Nourry H; Warnet JM; Barritault D; Baudouin C
J Fr Ophtalmol; 2008 May; 31(5):465-71. PubMed ID: 18641578
[TBL] [Abstract][Full Text] [Related]
3. Comparative Analysis of Matrix-Regenerating Agent and Corneal Cross-Linking in an Experimental Alkali Burn Rabbit Model.
Kesim E; Pirhan D; Yardimoglu Yilmaz M; Yuksel N; Yazir Y; Bicaklioglu G; Furat Rencber S
Curr Eye Res; 2022 Feb; 47(2):187-195. PubMed ID: 34435926
[TBL] [Abstract][Full Text] [Related]
4. Healing of resistant corneal neurotrophic ulcers using a matrix regenerating agent.
Cochener B; Zagnoli C; Hugny-Larroque C; Derrien S
J Fr Ophtalmol; 2019 Feb; 42(2):159-165. PubMed ID: 30573293
[TBL] [Abstract][Full Text] [Related]
5. The healing of alkali-injured cornea is stimulated by a novel matrix regenerating agent (RGTA, CACICOL20): a biopolymer mimicking heparan sulfates reducing proteolytic, oxidative and nitrosative damage.
Cejkova J; Olmiere C; Cejka C; Trosan P; Holan V
Histol Histopathol; 2014 Apr; 29(4):457-78. PubMed ID: 24105332
[TBL] [Abstract][Full Text] [Related]
6. Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers.
Aifa A; Gueudry J; Portmann A; Delcampe A; Muraine M
Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8181-5. PubMed ID: 23150626
[TBL] [Abstract][Full Text] [Related]
7. Matrix-Based Regenerating Agent for Corneal Wound Healing After Collagen Cross-Linking.
Hovakimyan M; Stachs O; Céline O; Guthoff RF
Cornea; 2016 Dec; 35(12):1638-1643. PubMed ID: 27755188
[TBL] [Abstract][Full Text] [Related]
8. Matrix Regeneration Therapy: A Case Series of Corneal Neurotrophic Ulcers.
Arvola RP; Robciuc A; Holopainen JM
Cornea; 2016 Apr; 35(4):451-5. PubMed ID: 26845313
[TBL] [Abstract][Full Text] [Related]
9. Anaylsis of birefringence during wound healing and remodeling following alkali burns in rabbit cornea.
Huang Y; Meek KM; Ho MW; Paterson CA
Exp Eye Res; 2001 Oct; 73(4):521-32. PubMed ID: 11825023
[TBL] [Abstract][Full Text] [Related]
10. Effects of new biomimetic regenerating agents on corneal wound healing in an experimental model of post-surgical corneal ulcers.
Alcalde I; Íñigo-Portugués A; Carreño N; Riestra AC; Merayo-Lloves JM
Arch Soc Esp Oftalmol; 2015 Oct; 90(10):467-74. PubMed ID: 26101128
[TBL] [Abstract][Full Text] [Related]
11. RGTA in corneal wound healing after transepithelial laser ablation in a rabbit model: a randomized, blinded, placebo-controlled study.
Xeroudaki M; Peebo B; Germundsson J; Fagerholm P; Lagali N
Acta Ophthalmol; 2016 Nov; 94(7):685-691. PubMed ID: 27227481
[TBL] [Abstract][Full Text] [Related]
12. Matrix therapy with RGTA OTR4120 improves healing time and quality in hairless rats with deep second-degree burns.
Zakine G; Barbier V; Garcia-Filipe S; Luboinski J; Papy-Garcia D; Chachques JC; Carpentier A; Barritault D
Plast Reconstr Surg; 2011 Feb; 127(2):541-550. PubMed ID: 21285759
[TBL] [Abstract][Full Text] [Related]
13. RGTA OTR4120, a heparan sulfate mimetic, is a possible long-term active agent to heal burned skin.
Garcia-Filipe S; Barbier-Chassefiere V; Alexakis C; Huet E; Ledoux D; Kerros ME; Petit E; Barritault D; Caruelle JP; Kern P
J Biomed Mater Res A; 2007 Jan; 80(1):75-84. PubMed ID: 16958049
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of alkali-induced corneal ulceration and perforation by a thiol peptide.
Burns FR; Gray RD; Paterson CA
Invest Ophthalmol Vis Sci; 1990 Jan; 31(1):107-14. PubMed ID: 2153643
[TBL] [Abstract][Full Text] [Related]
15. The Wound Healing Effects of Adiponectin Eye Drops after Corneal Alkali Burn.
Li Z; Cui L; Yang JM; Lee HS; Choi JS; Woo JM; Lim SK; Yoon KC
Curr Eye Res; 2016 Nov; 41(11):1424-1432. PubMed ID: 27159062
[TBL] [Abstract][Full Text] [Related]
16. Bovine lactoferrin promotes corneal wound healing and suppresses IL-1 expression in alkali wounded mouse cornea.
Pattamatta U; Willcox M; Stapleton F; Garrett Q
Curr Eye Res; 2013 Nov; 38(11):1110-7. PubMed ID: 23898919
[TBL] [Abstract][Full Text] [Related]
17. Use of amphoteric rinsing solution for treatment of ocular tissues exposed to nitrogen mustard.
Goldich Y; Barkana Y; Zadok D; Avni I; Berenshtein E; Rosner M; Chevion M
Acta Ophthalmol; 2013 Feb; 91(1):e35-40. PubMed ID: 23035792
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring.
Ferrari G; Bignami F; Giacomini C; Franchini S; Rama P
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1680-8. PubMed ID: 23404121
[TBL] [Abstract][Full Text] [Related]
19. CoQ10-containing eye drops prevent UVB-induced cornea cell damage and increase cornea wound healing by preserving mitochondrial function.
Mencucci R; Favuzza E; Boccalini C; Lapucci A; Felici R; Resta F; Chiarugi A; Cavone L
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7266-71. PubMed ID: 25301877
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of keratinocyte growth factor-2 accelerating corneal epithelial wound healing on rabbit alkali burned cornea].
Liu L; Li YP; Huang SQ; Lin JX; Zhang WX
Zhonghua Yan Ke Za Zhi; 2005 Apr; 41(4):364-8. PubMed ID: 15924701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
